A phase I study of an agonist anti-CD27 human antibody (CDX-1127) in patients with advanced hematologic malignancies or solid tumors. (7th November 2013) - Burris, Howard; Ansell, Stephen; Neumanitis, John; Weiss, Geoffrey; Sikic, Branimir; Northfelt, Donald; Pilja, Lana; Davis, Thomas; Yellin, Michael; Keler, Tibor; Bullock, Timothy